Dongdong Zhou

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.

Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: January 19, 2026

Characterization of tannic acid-intravenous immunoglobulin (IVIG) protein complex and impact on drug-induced cytotoxicity in MDA-MB-468 breast cancer cells.

Characterization of tannic acid-intravenous immunoglobulin (IVIG) protein complex and impact on drug-induced cytotoxicity in MDA-MB-468 breast cancer cells.

Journal: International journal of biological macromolecules

Published: March 21, 2025

Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition.

Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition.

Journal: Oncogene

Published: March 12, 2025

CENPU promotes tumorigenesis and stem cell properties in triple‑negative breast cancer by suppressing lysosomal furin degradation.

CENPU promotes tumorigenesis and stem cell properties in triple‑negative breast cancer by suppressing lysosomal furin degradation.

Journal: International journal of molecular medicine

Published: December 12, 2024

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

Journal: Clinical and translational medicine

Published: January 24, 2024

Identification of significant single-nucleotide polymorphisms associated with breast cancer recurrence and metastasis using GWAS.

Identification of significant single-nucleotide polymorphisms associated with breast cancer recurrence and metastasis using GWAS.

Journal: Cancer innovation

Published: January 03, 2024

Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.

Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.

Journal: Clinical breast cancer

Published: August 08, 2023

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.

Journal: eLife

Published: June 19, 2023

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages.

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages.

Journal: Cancer medicine

Published: February 21, 2023

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer.

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer.

Journal: Frontiers in genetics

Published: December 16, 2022

Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.

Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.

Journal: Annals of translational medicine

Published: October 20, 2022

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer.

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer.

Journal: Frontiers in oncology

Published: September 19, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026